Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT05056844
NA

Contrast Enhanced Spectral Mammography for the Evaluation of Pathologic Nipple Discharge

Sponsor: M.D. Anderson Cancer Center

View on ClinicalTrials.gov

Summary

This clinical trial studies contrast enhanced spectral mammography (CESM) for the evaluation of pathologic nipple discharge. CESM is similar to standard mammography, but it includes an intravenous (by vein) injection of an iodine-based contrast, which makes tissue and blood vessels more visible in scans. The goal of this trial is to learn if CESM, is better than standard mammography in quickly and efficiently determining the cause of nipple discharge and detecting breast cancer, if present. CESM may increase the chance of finding breast cancers and lower the risk of having unnecessary biopsies.

Official title: Contrast Enhanced Spectral Mammography (CESM) for the Evaluation of Pathologic Nipple Discharge: A Pilot Study

Key Details

Gender

FEMALE

Age Range

25 Years - 85 Years

Study Type

INTERVENTIONAL

Enrollment

66

Start Date

2021-04-15

Completion Date

2027-04-30

Last Updated

2025-10-09

Healthy Volunteers

No

Interventions

PROCEDURE

Contrast Enhanced Digital Mammography

Undergo CESM

PROCEDURE

Digital Tomosynthesis Mammography

Undergo DBT

DRUG

Iodinated Contrast Agent

Given iodine-based contrast agent IV

OTHER

Questionnaire Administration

Ancillary studies

Locations (1)

M D Anderson Cancer Center

Houston, Texas, United States